A representative picture showing upregulated HIF-2α mRNA and protein levels in NALFD-HCC patients suggest that HIF-2α may play a role in NAFLD-HCC. This evidence concerns the gene EPAS1 and metabolic dysfunction-associated steatotic liver disease.